| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 2066 | 2019 |
| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 829 | 2020 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 425 | 2024 |
| Prevention and treatment of childhood and adolescent obesity: a systematic review of meta-analyses T Psaltopoulou, S Tzanninis, I Ntanasis-Stathopoulos, G Panotopoulos, ... World journal of pediatrics 15, 350-381, 2019 | 111 | 2019 |
| Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention M Kostopoulou, D Nikolopoulos, I Parodis, G Bertsias Current Vascular Pharmacology 18 (6), 549-565, 2020 | 108 | 2020 |
| Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant … M Kostopoulou, A Fanouriakis, K Cheema, J Boletis, G Bertsias, D Jayne, ... RMD open 6 (2), e001263, 2020 | 64 | 2020 |
| Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset … D Nikolopoulos, M Kostopoulou, A Pieta, T Karageorgas, D Tseronis, ... Lupus 29 (5), 514-522, 2020 | 59 | 2020 |
| An update on the diagnosis and management of lupus nephritis M Kostopoulou, C Adamichou, G Bertsias Current Rheumatology Reports 22, 1-12, 2020 | 36 | 2020 |
| Access to kidney transplantation in European adults aged 75–84 years and related outcomes: an analysis of the European Renal Association–European Dialysis and Transplant … M Pippias, VS Stel, A Kramer, JM Abad Diez, N Aresté‐Fosalba, C Ayav, ... Transplant International 31 (5), 540-553, 2018 | 34 | 2018 |
| Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease DS Nikolopoulos, M Kostopoulou, A Pieta, S Flouda, K Chavatza, ... Lupus Science & Medicine 7 (1), e000394, 2020 | 33 | 2020 |
| Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients K Chavatza, M Kostopoulou, D Nikolopoulos, O Gioti, K Togia, L Andreoli, ... Annals of the rheumatic diseases 80 (9), 1175-1182, 2021 | 22 | 2021 |
| The association between lupus serology and disease outcomes: a systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus M Kostopoulou, MF Ugarte-Gil, B Pons-Estel, RF van Vollenhoven, ... Lupus 31 (3), 307-318, 2022 | 15 | 2022 |
| Preventing infections in immunocompromised patients with kidney diseases: vaccines and antimicrobial prophylaxis M Windpessl, M Kostopoulou, R Conway, I Berke, A Bruchfeld, MJ Soler, ... Nephrology Dialysis Transplantation 38 (Supplement_2), ii40-ii49, 2023 | 12 | 2023 |
| Trends in mortality due to myocardial infarction, stroke, and pulmonary embolism in patients receiving dialysis G Ocak, R Boenink, M Noordzij, WJW Bos, BE Vikse, A Cases, ... JAMA Network Open 5 (4), e227624-e227624, 2022 | 12 | 2022 |
| Lupus nephritis: improving treatment options M Kostopoulou, S Pitsigavdaki, G Bertsias Drugs 82 (7), 735-748, 2022 | 11 | 2022 |
| Treatment of lupus: more options after a long wait M Kostopoulou, A Fanouriakis, G Bertsias, DT Boumpas Annals of the Rheumatic Diseases 81 (6), 753-756, 2022 | 9 | 2022 |
| Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations M Kostopoulou, CB Mukhtyar, G Bertsias, DT Boumpas, A Fanouriakis Annals of the Rheumatic Diseases, 2024 | 7 | 2024 |
| Hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant K Liapis, P Panagopoulou, E Charitaki, D Rowczenio, J Gilbertson, ... Amyloid 26 (1), 52-53, 2019 | 7 | 2019 |
| Annals of the Rheumatic Diseases collection on lupus nephritis (2019–2022): novel insights and advances in therapy M Kostopoulou, A Fanouriakis, G Bertsias, DT Boumpas Annals of the Rheumatic Diseases 82 (6), 729-733, 2023 | 6 | 2023 |
| Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’by Fanouriakis et al A Fanouriakis, G Bertsias, DT Boumpas Annals of the rheumatic diseases 83 (11), e25-e25, 2024 | 4 | 2024 |
